510(K) Submission - A Comprehensive and an Updated Overview

  • Speaker:Dr. David Lim
  • Date: 16th November 2017 10:00 AM PST | 01:00 PM EST
  • Duration:90Min
  • Product Code:GRC-90188

$239

refer

Refer Friend's


Live Session - How it works

  • Username and Password will be sent to you 24 hours prior to the webinar.
  • Presentation handouts in pdf format will be mailed to you.
  • Login to the session using the username and password provided to you.
  • Get answer to your queries through interactive Q&A sessions via chat.
  • Please let us know your thoughts and views at the end of webinar, your valuable feedback will help us improve.
  • Get certification of attendance.

Recorded Session - How it works

  • Login Information with Password to view the webinar, 24 hours after the Live webinar (link valid for 6 months).
  • A link will be provided to you upon purchase of the recorded session.
  • Please click on the link to access the session.
  • Presentation handouts in pdf format will be mailed to you.
  • Get certification of attendance.

Training CD - How it works

  • Free shipment within 72 Hours, from the date of webinar completion.

(More about our products contact +1- 248-233-2049)

We offer face to face and online training. If you have 5 or more people interested in learning this topic. Contact our support to set up a date. 

Why should you attend:


The section [510(k)] of the Federal Food, Drug, and Cosmetic Act (FD&C Act or the Act) prescribes the premarket notification requirements. The premarket notification [510(k)] is the most common pathway to market for medical devices including in vitro diagnostic medical devices (IVDs).  The 510(k) premarket submission is made to US FDA to demonstrate that the subject device (to be marketed) is substantially equivalent (as least as safe and effective) to a legally marketed device(s) (predicate device) as described in 21 CFR 807.92(a)(3).  In other words, firms must demonstrate that a proposed product is substantially equivalent to another, a legally marketed medical device that is also lower-risk and is not subject to premarket approval (PMA). Over time, the 510(k) program has significantly evolved, affecting the 510(k) decision-making process.

To expedite the process of bringing a product to market through the 510(k) program, it is imperative that the medical device manufacturers understand how to expedite the FDA review process leading to a prompt clearance in view of recent trends and customized strategy for a successful clearance. This presentation is intended to demonstrate how to improve submission quality, which will subsequently prevent avoidable delays and reduce review times.

In this webinar, we will discuss:

  •     Statute(s) and Regulations
  •     Definitions
  •     Medical Device Classification
  •     510(k) Process
  •     Selecting Predicate Device(s)
  •     De Novo Process – Practical Advice
  •     How To Demonstrate Substantial Equivalence
  •     510(K) Contents And Format
  •     Addressing Technical And Regulatory Requirements.
  •     510(k) Submission Quality For A Product-Be Aware.
  •     Responding to FDA’s Request Of Additional Information.
  •     Resolving Different Opinions Between The Submitter And FDA Reviewer(S).
  •     Avoiding Common Mistakes with Awareness
  •     510(k) Trends
  •     510(k) Preparation: Dos and Don’ts for Best Practices
  •     Speaker’s PASS-IT Recommendations

This webinar will be valuable for anyone in the FDA-regulated industry including, but not limited to, medical device, drugs, biologics and in vitro diagnostic devices. It is particularly useful for those who are engaged in the design and development of medical devices, combinations products (e.g., drug and devices, biologic and devices), and in Vitro diagnostic devices including companion medical products. This webinar is a must for those who are directly or indirectly involved in handling 510(k) regulatory submissions to the FDA.

Who will benefit:
  •     Personnel involved in regulatory affairs (associates, specialists, managers, and directors).
  •     Personnel involved in clinical affairs (associates, specialists, coordinators, managers and directors)
  •     Personnel involved in quality assurance, quality control and quality systems (associates, specialists, engineers, managers, and directors)
  •     Personnel involved in research and development (associates, scientists, managers, and directors)
  •     Site managers, and consultants
  •     Other interested stakeholders (upper management personnel)  

Instructor Profile:
Dr. David Lim, Ph.D., RAC, ASQ-CQA.  Dr. Lim is President and Principal of Regulatory Doctor.  As a leading industry speaker, Dr. Lim frequently presents global regulatory and quality compliance topics in various forums and meetings.  Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past eight years.  Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009.
Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker.  Dr. Lim leads and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor.  

Available Options

Recording: Access it for 6 months from any location

$239

CD: Shipped within 2 working days

$339

5 Member Group: Access the Live Meeting online from any location globally

$1,139

10 Member group: Access the Live Meeting online from any location globally

$1,869

Recording: 24 Hour Access Only

$39
For discounts and offers call support

Related Products

Root Cause Analysis and CAPA

Root Cause Analysis and CAPA

We offer face to face and online training. If you have 5 or more people interested in learning this topic. Contact our support to set up a date. Description: Conducting an effective root cause analysis can be a daunting task. And without a good root cause analysis, your CAPA will not result in the desired improvement. This webinar will give you insights and lessons learned from an industry expert with over 30 years’ experience. You will learn how to get permanent resolution to your seri..

$249

How to Prepare Yourself for FDA's on-going Part 11 Inspection Program

How to Prepare Yourself for FDA's on-going Part 11 Inspection Program

We offer face to face and online training. If you have 5 or more people interested in learning this topic. Contact our support to set up a date. Description :FDA continues to enforce Part 11 through its new Part 11 inspection and enforcement program. Just in the last 3 years, FDA issued more than 30 warning letters with Part 11 violations. Citations are related to inadequate integrity, security and availability of electronic records but also related to validation of software and computer sy..

$249

Best Practices for Preparing for a Technical File for CE Mark

Best Practices for Preparing for a Technical File for CE Mark

This webinar is intended to help you get familiar with how to prepare for a technical file (or design dossier) and submit it to a notified body for CE marking purposes under directives governing medical devices: medical devices including in vitro diagnostic and active implantable medical devices. This webinar is further intended to provide guidance on the regulatory requirements set out in the applicable Directives, which help assure that medical devices are safe and effective for their intende..

$209